MGHP3 Study: New Insights into Postpartum Psychosis

Understanding Postpartum Psychosis: A Critical Overview

Postpartum psychosis (PP) is a severe but rare mental health condition that can affect women following childbirth. While affecting approximately 1 to 2 per 1,000 women, its infrequency and inconsistent classification have historically made systematic research challenging. This has resulted in significant knowledge gaps regarding its diagnosis, management, and underlying causes, leaving many healthcare providers with limited experience in identifying and treating it. The Mass General Hospital Postpartum Psychosis Project (MGHP3) was established to address these limitations, aiming to provide a deeper, more nuanced understanding of this critical condition.

The Mass General Hospital Postpartum Psychosis Project (MGHP3)

Launched in 2018 by Dr. Lee Cohen, Dr. Rachel Vanderkruik, and Dr. Marlene Freeman from the Ammon-Pinizzotto Center for Women’s Mental Health, the MGHP3 project was designed to collect comprehensive data on postpartum psychosis. The project's overarching goal is to expand our understanding of the phenomenology of PP within a diverse cohort of women. Specifically, it aims to:

• Identify risk factors for postpartum psychosis.
• Better characterise its clinical presentation.
• Advance our understanding of the underlying causes of this severe condition.

Study Design and Data Collection

The MGHP3 study employs a robust design to gather extensive information. It actively recruits women who have experienced psychosis within six months of childbirth and are within ten years of their most recent episode. Data is collected through a structured clinical interview, conducted via phone or Zoom, which includes the Mini International Neuropsychiatric Interview for Psychotic Disorders Studies and the MGHP3 Questionnaire. This comprehensive approach gathers a wide range of demographic and clinical information, including:

• Timing of illness onset.
• Symptom patterns.
• Co-occurring conditions.
• Psychiatric diagnoses before and after the PP episode.
• Details on treatment received.

Furthermore, participants provide saliva samples for genetic analysis, and a subset undergoes neuroimaging assessments to explore potential biological factors contributing to postpartum psychosis. This multi-faceted approach ensures a holistic view of the condition.

Preliminary Findings: A Glimpse into Postpartum Psychosis

Preliminary results from the MGHP3 study, analysing data from 248 participants (representing 258 episodes of postpartum psychosis), have provided significant insights. Participants were drawn from 41 U.S. states, Washington D.C., and 7 countries, highlighting the project's broad reach. The time between the initial PP episode and the study interview varied considerably, with a mean of approximately 3.22 years.

Clinical Characteristics of Postpartum Psychosis

A key finding from the study is the varying psychiatric history of participants. Prior to their first PP episode, 38.3% had no prior psychiatric diagnosis, while 61.7% had at least one. Of those with a previous psychiatric history, 12.5% had a history of psychosis, most commonly associated with Bipolar I Disorder with psychotic features, Major Depressive Disorder with psychotic features, or Brief Psychotic Disorder. Notably, at the time of their first PP episode, nearly 72% of participants met criteria for Bipolar I Disorder with psychotic features. Among the participants, 10 experienced recurrent postpartum psychosis, with 6 diagnosed again with Bipolar I Disorder with psychotic features and 4 classified as Brief Psychotic Disorder.

Timing, Duration, and Symptom Patterns

The study also shed light on the timing and duration of PP symptoms. The median time between delivery and symptom onset was 10 days. The duration of psychotic symptoms showed significant variation:

The median time to return to psychiatric baseline was 25 weeks for all participants, with 10 weeks for those with recurrent PP. Symptom patterns also varied, with 45.7% reporting waxing and waning symptoms and 51.9% experiencing more continuous symptoms. The most commonly reported symptoms included:

• Odd beliefs or delusions – 87.6%
• Persecutory delusions – 75.2%
• Delusions of reference – 55.8%
• Visual hallucinations – 52.3%
• Auditory hallucinations – 48.06%

Treatment in the Context of Postpartum Psychosis

During the postpartum period, participants received a range of treatments. The majority (93.0%) received medication, 74.4% were hospitalized, and 65.9% received psychotherapy. The most commonly used medications were atypical antipsychotics (81.0%), followed by SSRIs (50.0%), benzodiazepines (47.3%), lithium (28.7%), lamotrigine (18.6%), and valproic acid (9.3%). This data highlights the common treatment modalities employed for PP.

Clinical Implications and Future Directions

The MGHP3 cohort represents one of the largest clinically assessed cohorts of individuals with postpartum psychosis globally. Unlike many previous studies that relied on registry data or smaller samples, MGHP3 offers a broader, more nuanced view. The study's findings underscore the heterogeneity of postpartum psychosis, suggesting it may not always be linked to bipolar disorder, a crucial point for diagnosis and treatment. The finding that approximately one-third of participants experienced symptoms for longer than a month emphasizes the potential for prolonged illness and the need for effective treatment strategies to minimize symptom duration and long-term effects.

The MGHP3 study lays a critical foundation for future research by integrating translational reproductive neuroscience and genomic research. As further studies are conducted, this work will contribute to a more holistic understanding of postpartum psychosis and aid in identifying effective, individualised treatments for affected women. The project continues to actively recruit participants, with 445 enrolled as of December 18, 2024, promising even richer insights in the future.

When to Seek Urgent Medical Help for Postpartum Psychosis

Postpartum psychosis is a medical emergency. Symptoms typically start suddenly within the first two weeks after giving birth, often within hours or days, though they can develop later. Symptoms can include:

• Hallucinations (seeing, hearing, smelling, or feeling things that aren't there).
• Delusions (unlikely beliefs or suspicions).
• Mania (feeling very "high", overactive, rapid thoughts and speech, restlessness, loss of inhibitions).
• Low mood (depression, withdrawal, tearfulness, lack of energy, appetite loss, anxiety, agitation, sleep disturbances).
• Rapidly changing moods.
• Confusion.

If you suspect you or someone you know has symptoms of postpartum psychosis, it is vital to seek immediate medical attention. Contact a GP for an urgent assessment on the same day. If you cannot reach a GP, call 111. Midwives or health visitors can also help access care. If you have a care plan due to a high risk of PP, contact your crisis team. In cases of imminent danger to self or others, go to A&E or call 999. It's important to remember that individuals experiencing PP may not recognise they are ill, making the support of partners, family, and friends crucial in seeking help.

Treatment and Recovery

Treatment for postpartum psychosis usually occurs in a hospital setting, ideally in a specialist mother and baby unit (MBU) with the baby. If an MBU is unavailable, admission to a general psychiatric ward may be necessary. Most individuals make a full recovery with appropriate treatment. Common treatments include:

• Antipsychotics: To manage manic and psychotic symptoms like delusions and hallucinations.
• Mood stabilisers (e.g., Lithium): To stabilise mood and prevent recurrence.
• Antidepressants: To alleviate depressive symptoms, often used alongside mood stabilisers.
• Electroconvulsive Therapy (ECT): Considered if other treatments fail or in life-threatening situations.
• Psychological therapy (e.g., CBT): Beneficial during recovery to manage thoughts and behaviours.

Peer support from individuals with lived experience can also be invaluable, with organisations like Action on Postpartum Psychosis offering support.

Risk Factors and Prevention

While the exact causes of postpartum psychosis are not fully understood, increased risk factors include a prior diagnosis of bipolar disorder or schizophrenia, a family history of mental illness (especially PP), and having experienced PP after a previous pregnancy. For those at high risk, specialist care during pregnancy, regular perinatal psychiatric reviews, and pre-birth planning meetings involving all care providers and family are crucial. A clear care plan, detailing how to get help quickly and strategies to reduce risk, should be established. Regular home visits from midwives, health visitors, and mental health nurses in the early weeks after birth are also vital.

Frequently Asked Questions

Q1: What is the main difference between the 'baby blues' and postpartum psychosis?
The 'baby blues' are mild mood changes that are normal and usually resolve within a few days. Postpartum psychosis is a severe mental illness with symptoms like hallucinations, delusions, and mania, requiring urgent medical treatment.

Q2: Can a traumatic birth cause postpartum psychosis?
While the exact causes of postpartum psychosis are complex and not fully understood, a traumatic birth can be a significant stressor. However, the primary identified risk factors are pre-existing mental health conditions like bipolar disorder, family history of mental illness, and previous episodes of PP. Research is ongoing to explore all potential contributing factors.

Q3: How long do postpartum psychosis symptoms typically last?
Symptom duration varies. The MGHP3 study found that 60.9% of participants experienced symptoms lasting between 1 day and 1 month, but 24.0% had symptoms lasting 1 to 6 months, and 10.47% experienced symptoms for over 6 months. Prompt and appropriate treatment is key to recovery.

Q4: Is postpartum psychosis treatable?
Yes, postpartum psychosis is treatable. With the right medical intervention, including medication and therapy, most women make a full recovery. Early diagnosis and treatment are crucial for the best outcomes for both mother and baby.

Q5: Where can I find support if I or someone I know is affected by postpartum psychosis?
Support is available from healthcare professionals, including GPs, midwives, and mental health teams. Charities like Action on Postpartum Psychosis offer online and in-person support. Crisis helplines and mental health services are also available for urgent assistance.

If you want to read more articles similar to MGHP3 Study: New Insights into Postpartum Psychosis, you can visit the Automotive category.